• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Hyderus

Hyderus Cyf and Hyderus Teoranta

Pandemicast
  • Home
  • Tell the Truth
    • Videos
  • About us
    • Access to innovative medicines
    • New Work in India
    • Mark Chataway
    • We pay our taxes
    • Our approach to managing risk perception and crises
    • African journalists we respect
  • Customers
  • Expertise
    • Development and Politics
      • Assessing science policy in 48 African countries
      • The future of European development funding
      • The link between family planning and climate change
      • What are the influence networks in health?
    • Knowledge Transfer and Capacity Building
      • For senior executives
      • For the online world
      • To manage international politics
    • Public Health
      • Drivers and barriers for new vaccines
    • Strategic Planning
      • Avoiding a crisis in the Middle East
      • Developing BRICS countries as donors
      • For an international organisation in India
      • Increasing immunization coverage in central India
      • Setting up systems for issues management
    • Treatment Decisions
      • How to get healthcare systems to care for older women
      • Immunisation for adults
      • Stakeholders and corporate social responsibility
  • Contact
  • Blog
    • What we’re thinking
    • Our World
    • Staff blog
  • Flexible Pricing Plan

india

Indian patent laws, no longer the pharmacy of the developing world?

March 18, 2018 by Nicholas Parry Leave a Comment

Copyright: lesniewski / 123RF Stock Photo

India holds a unique position in the generic market. Commonly referred to as the “pharmacy of the developing world”, India exports huge volumes of generic medication. This forms a multi-billion dollar industry within India. This low cost generics market has improved access to lower price medications in India, as well as allowed for the export … [Read more...] about Indian patent laws, no longer the pharmacy of the developing world?

Filed Under: Featured, Our craft, Staff blog Tagged With: China, evergreening, india, Patent law, Pfizer

What India will really do about access to innovative medicines

March 29, 2016 by Chris Nial Leave a Comment

Recent controversy about access and IP Will India risk the wrath of many of its trading partners by issuing more compulsory licences to give access to innovative medicines? The question has flared to life again over the past few weeks. In early March, US trade groups sounded triumphal: India had assured the Americans that it would respect the … [Read more...] about What India will really do about access to innovative medicines

Filed Under: Featured Tagged With: access, access to medicines, compulsory licence, compulsory license, india

India’s new medicine taxes hit the poor and the sick

February 14, 2016 by Mark Chataway 1 Comment

India surprised the world this week by announcing that it would impose taxes on many imported medicines. It will remove customs duty waivers and impose excise duty on 76 medicines used to treat cancer, HIV, haemophilia, diabetes and other diseases. The Times of India reported that this might “result in price increases between 10-25 percent on both … [Read more...] about India’s new medicine taxes hit the poor and the sick

Filed Under: Featured Tagged With: access to medicines, india, pharmaceutical industry, taxes on medicines

Business travellers matter more than sick people say developing country governments

December 31, 2013 by Mark Chataway 1 Comment

If, like me, you travel a lot to India and Africa, I have good news: business class fares are going to stay low or even fall in 2014. This is thanks to generous subsidies from the governments of some of the countries with the highest burdens of disease in the world. This October 2013 article from CAPA, the Centre for Aviation, lists the $2.5 … [Read more...] about Business travellers matter more than sick people say developing country governments

Filed Under: Featured Tagged With: Africa, health policy, india, public health

Reasons #polio may not be eradicated by 2018: a journal trips over itself #GPEI

October 30, 2013 by Mark Chataway Leave a Comment

An article in the current PLoS Medicine is sure to ruffle feathers amongst those committed to polio eradication by questioning whether polio can or should be eradicated by 2018. An independent expert board has concluded that there is a realistic prospect of no new transmission by 2014 but the authors of the PLoS paper think that even 2018 is too … [Read more...] about Reasons #polio may not be eradicated by 2018: a journal trips over itself #GPEI

Filed Under: Featured Tagged With: eradication, india, polio

India’s policy in #greenenergy and #cleantech #patents is “expropriation” says newspaper

October 5, 2013 by Mark Chataway Leave a Comment

India apparently plans to force the holders of green energy patents to license their innovations to Indian companies. As we noted earlier this week, this seems a bold extension of a policy that has already had a limited use in the health and pharma sector. India can do this under the National Manufacturing Policy. The NMP says that the government … [Read more...] about India’s policy in #greenenergy and #cleantech #patents is “expropriation” says newspaper

Filed Under: Featured Tagged With: cleantech, green energy, india, patents

India may start seizing #patent rights for #greenenergy

October 3, 2013 by Mark Chataway Leave a Comment

There is a long and complicated tussle over patents in the pharma sector in India. Over the year, India has issued two compulsory licences for pharmaceuticals and made a number of other moves seen as hostile to patent holders (see this recent article on our sister site, Health Issues India) Now, according to Business Line  (part of the respected … [Read more...] about India may start seizing #patent rights for #greenenergy

Filed Under: Featured Tagged With: compulsory licence, compulsory license, green energy, green technology, india

India’s patent system on medicine may be the new normal #accesstomedicine #india

September 17, 2013 by Mark Chataway 1 Comment

There has been a lot of wailing amongst multinational pharma companies about India's uniquely unfriendly attitude to patents. Now, it might be starting to look like the new normal. The MNC's are worried about three separate developments in India that they think will reduce incentives for innovation Compulsory licences where a local … [Read more...] about India’s patent system on medicine may be the new normal #accesstomedicine #india

Filed Under: Featured Tagged With: india, patents

Primary Sidebar

Categories

  • Featured (206)
  • Our craft (22)
  • Staff blog (56)
access to medicines Africa Chris Nial climate change communications consultancy coronavirus COVID-19 Development Donald Trump environment foreign policy Global Health Progress global warming green energy health healthcare health policy HIV Hyderus india Mark Chataway ODA PandemiCast patents pharmaceutical industry public health vaccination vaccines wales WHO

Hyderus on Twitter

Tweets by Hyderus

Hyderus on Facebook

Videos

The Three Commitments
Why Consultants end up not telling the truth
The worst kind of market research interviewing technique ever
Why bright people can’t explain themselves
More videos

Clients

 
 
 

Footer

Looking For?

  • Our World
  • Contact us
  • Privacy Policy
  • Terms of use

Recent Posts

  • Accessible healthcare could aid climate crisis in rainforest communities
  • Climate change impact has the potential to regress cancer progress through healthcare disruption, according to study
  • Vaccines and COVID-19: Frans van den Boom speaks to Hyderus and Baird’s CMC

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Copyright © 2021 Hyderus. All rights reserved. Sitemap

  • Home
  • Tell the Truth
    ▼
    • Videos
  • About us
    ▼
    • Access to innovative medicines
    • New Work in India
    • Mark Chataway
    • We pay our taxes
    • Our approach to managing risk perception and crises
    • African journalists we respect
  • Customers
  • Expertise
    ▼
    • Development and Politics
      ▼
      • Assessing science policy in 48 African countries
      • The future of European development funding
      • The link between family planning and climate change
      • What are the influence networks in health?
    • Knowledge Transfer and Capacity Building
      ▼
      • For senior executives
      • For the online world
      • To manage international politics
    • Public Health
      ▼
      • Drivers and barriers for new vaccines
    • Strategic Planning
      ▼
      • Avoiding a crisis in the Middle East
      • Developing BRICS countries as donors
      • For an international organisation in India
      • Increasing immunization coverage in central India
      • Setting up systems for issues management
    • Treatment Decisions
      ▼
      • How to get healthcare systems to care for older women
      • Immunisation for adults
      • Stakeholders and corporate social responsibility
  • Contact
  • Blog
    ▼
    • What we’re thinking
    • Our World
    • Staff blog
  • Flexible Pricing Plan

Cookies

This site uses cookies: Find out more.